Notably, accumulating studies have shown that SPAG6 expression is correlated with the pathogenesis of myelodysplastic syndrome (MDS) and Burkett lymphoma (BL) [33–37]. This evidence concerns the gene SPAG6 and Burkitt lymphoma.